Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients.
Chelle P, Yeung CHT, Bonanad S, Morales Muñoz JC, Ozelo MC, Megías Vericat JE, Iorio A, Spears J, Mir R, Edginton A. Chelle P, et al. Among authors: bonanad s. J Pharmacokinet Pharmacodyn. 2019 Oct;46(5):439. doi: 10.1007/s10928-019-09647-2. J Pharmacokinet Pharmacodyn. 2019. PMID: 31302829 Free PMC article.
The article Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients, written by Pierre Chelle, Cindy H. T. Yeung, Santiago Bonanad, Juan Cristobal Morales Munoz, Margareth C. Ozelo, Juan Eduardo Megias Veri …
The article Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients, writ …
Pilot evaluation of home delivery programme in haemophilia.
Megías-Vericat JE, Monte-Boquet E, Martín-Cerezuela M, Cuéllar-Monreal MJ, Tarazona-Casany MV, Pérez-Huertas P, Bonanad S, Poveda-Andrés JL. Megías-Vericat JE, et al. Among authors: bonanad s. J Clin Pharm Ther. 2018 Dec;43(6):822-828. doi: 10.1111/jcpt.12718. Epub 2018 Jun 15. J Clin Pharm Ther. 2018. PMID: 29906305
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate® ) and BAY 81-8973 (Kovaltry® ) in patients with severe or moderate haemophilia A in prophylaxis.
Megías-Vericat JE, Bonanad S, Haya S, Cid AR, Marqués MR, Monte-Boquet E, Pérez-Alenda S, Bosch P, Querol F, Poveda JL. Megías-Vericat JE, et al. Among authors: bonanad s. Haemophilia. 2019 May;25(3):e215-e218. doi: 10.1111/hae.13733. Epub 2019 Mar 13. Haemophilia. 2019. PMID: 30866068 No abstract available.
Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients.
Chelle P, Yeung CHT, Bonanad S, Morales Muñoz JC, Ozelo MC, Megías Vericat JE, Iorio A, Spears J, Mir R, Edginton A. Chelle P, et al. Among authors: bonanad s. J Pharmacokinet Pharmacodyn. 2019 Oct;46(5):427-438. doi: 10.1007/s10928-019-09637-4. Epub 2019 May 21. J Pharmacokinet Pharmacodyn. 2019. PMID: 31115857 Free PMC article.
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup.
Chelle P, Yeung CHT, Croteau SE, Lissick J, Balasa V, Ashburner C, Park YS, Bonanad S, Megías-Vericat JE, Nagao A, Wynn T, Corrales-Medina F, Tran H, Sharathkumar A, Chitlur M, Sarmiento S, Edginton A, Iorio A. Chelle P, et al. Among authors: bonanad s. Clin Pharmacokinet. 2020 Feb;59(2):245-256. doi: 10.1007/s40262-019-00809-6. Clin Pharmacokinet. 2020. PMID: 31435896
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients.
Megías-Vericat JE, Bonanad S, Haya S, Cid AR, Marqués MR, Ferrada A, Monte-Boquet E, Pérez-Alenda S, Bosch P, Querol-Giner F, Poveda JL. Megías-Vericat JE, et al. Among authors: bonanad s. Thromb Res. 2021 Sep;205:99-105. doi: 10.1016/j.thromres.2021.07.009. Epub 2021 Jul 15. Thromb Res. 2021. PMID: 34293540
97 results